These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7009115)

  • 1. Aspects of continuous subcutaneous insulin infusion (CSII) in diabetes.
    Keen H; Pickup JC; Viberti GC; Bilous R; Williams G
    Diabetes Care; 1981; 4(1):54-7. PubMed ID: 7009115
    [No Abstract]   [Full Text] [Related]  

  • 2. Continuous subcutaneous insulin infusion: a developing tool in diabetes research.
    Pickup JC; Keen H
    Diabetologia; 1980 Jan; 18(1):1-4. PubMed ID: 6988262
    [No Abstract]   [Full Text] [Related]  

  • 3. Newer insulin delivery systems: continuous subcutaneous insulin infusion.
    Pickup JC; Keen H; Parsons JA; Alberti KG
    Adv Exp Med Biol; 1979; 119():491-5. PubMed ID: 495298
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical application of pre-programmed insulin infusion: continuous subcutaneous insulin therapy with a portable infusion system.
    Pickup JC; Viberti GC; Keen H; Parsons JA; Alberti KG
    Horm Metab Res Suppl; 1979; (8):202-4. PubMed ID: 395081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of glucose-controlled insulin infusion system for improvement of subcutaneous insulin regimen.
    Irsigler K; Kritz H; Kaspar L; Brändle J; Franetzki M
    Horm Metab Res Suppl; 1979; (8):134-40. PubMed ID: 395070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term, ambulatory, subcutaneous insulin infusion versus multiple daily injections in brittle diabetic patients.
    Barbosa J; Menth L; Eaton J; Sutherland D; Freier EF; Najarian J
    Diabetes Care; 1981; 4(2):269-74. PubMed ID: 7011745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a closed-loop artificial pancreas.
    Kraegen EW; Whiteside R; Bell D; Chia YO; Lazarus L
    Horm Metab Res Suppl; 1979; (8):38-42. PubMed ID: 395087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control algorithms for artificial beta cell.
    Clemens AH
    Horm Metab Res Suppl; 1979; (8):35-8. PubMed ID: 395086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical application of insulin: a perspective.
    Marble A
    Diabetes Care; 1981; 4(1):45-6. PubMed ID: 7009113
    [No Abstract]   [Full Text] [Related]  

  • 10. The artificial beta cell--a continuous control of blood sugar by external regulation of insulin infusion (glucose controlled insulin infusion system).
    Pfeiffer EF; Thum C; Clemens AH
    Horm Metab Res; 1974 Sep; 6(5):339-42. PubMed ID: 4607598
    [No Abstract]   [Full Text] [Related]  

  • 11. Insulin responses to mixed meals: comparison of an artificial beta cell and normal beta cells.
    Horwitz DL
    Horm Metab Res Suppl; 1979; (8):68-71. PubMed ID: 395093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of daily insulin requirements in diabetics with an artificial endocrine pancreas.
    Lambert AE; Buysschaert M; Lambotte L
    Horm Metab Res Suppl; 1979; (8):120-7. PubMed ID: 395067
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapeutical application of artificial beta-cell in surgery and obstetrics.
    Brunetti P; Puxeddu A; Calabrese G; Massi-Benedetti M; Santeusanio F; Bolli G; Scionti L; Bueti A; Angeletti G
    Horm Metab Res Suppl; 1979; (8):162-5. PubMed ID: 395074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood glucose monitoring and computer regulation by means of an artificial endocrine pancreas.
    Kruse-Jarres JD; Braun G; Naegele R; Bresch M; Lehmann U
    Horm Metab Res Suppl; 1979; (8):42-5. PubMed ID: 395088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Present and future expectations regarding insulin infusion systems.
    Marliss EB; Caron D; Albisser AM; Zinman B
    Diabetes Care; 1981; 4(2):325-7. PubMed ID: 7011751
    [No Abstract]   [Full Text] [Related]  

  • 16. Overnight metabolic control with bedtime injection of intermediate-acting insulin or continuous subcutaneous insulin infusion.
    Olsson PO; Arnqvist H; Von Schenck H; Ottosson AM
    Diabetes Care; 1987; 10(6):702-6. PubMed ID: 3322726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of an artificial beta cell in surgery.
    Horwitz DL; Schwartz SS
    Horm Metab Res Suppl; 1979; (8):156-8. PubMed ID: 395072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical control of diabetes by the artificial pancreas.
    Albisser AM; Leibel BS; Ewart TG; Davidovac Z; Botz CK; Zingg W; Schipper H; Gander R
    Diabetes; 1974 May; 23(5):397-404. PubMed ID: 4598090
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of insulin infusion kinetics of an artificial beta cell on blood glucose control in insulin-dependent diabetics.
    Kerner W; Beischer W; Maier V; Pfeiffer EF
    Horm Metab Res Suppl; 1979; (8):71-80. PubMed ID: 395094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of cortisol circadian variations on insulin need and delivery in insulin-dependent diabetics. Assessment by the artificial beta cell.
    Altomare E; Moulin JP; Tavares S; Bourelly N; Lassmann V; Vague P
    Horm Metab Res Suppl; 1979; (8):110-5. PubMed ID: 395065
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.